{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:37:54Z","timestamp":1789702674827,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.xops.2023.100403","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:00:32Z","timestamp":1694818832000},"page":"100403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The 0.2-\u03bcg\/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis"],"prefix":"10.1016","volume":"4","author":[{"given":"Jyotirmay","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2023.100403_bib1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2147\/OPTH.S89341","article-title":"Management of noninfectious posterior uveitis with intravitreal drug therapy","volume":"10","author":"Tan","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2023.100403_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40123-022-00456-4","article-title":"The use of sustained release intravitreal steroid implants in non-infectious uveitis affecting the posterior segment of the eye","volume":"11","author":"Abdulla","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.xops.2023.100403_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archophthalmol.2008.610","article-title":"Diabetic Retinopathy Clinical Research Network (DRCR.net). Three-year follow-up of a randomized trial comparing focal\/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema","volume":"127","author":"Beck","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2023.100403_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.xops.2023.100403_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-020-01314-y","article-title":"Uveitis therapy: the corticosteroid options","volume":"80","author":"Valdes","year":"2020","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.xops.2023.100403_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.ophtha.2015.06.042","volume":"122","author":"Kempen","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.xops.2023.100403_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12348-020-00225-z","article-title":"Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2 mug\/day fluocinolone acetonide intravitreal implant (ILUVIEN((R)))","volume":"10","author":"Bodaghi","year":"2020","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"issue":"3","key":"10.1016\/j.xops.2023.100403_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ophtha.2012.09.014","article-title":"Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2023.100403_bib9","series-title":"ILUVIEN [Ireland Prescribing Information]","year":"2019"},{"key":"10.1016\/j.xops.2023.100403_bib10","series-title":"YUTIQ [Prescribing Information]","year":"2021"},{"issue":"10","key":"10.1016\/j.xops.2023.100403_bib11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2020.04.001","article-title":"Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results","volume":"127","author":"Jaffe","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.xops.2023.100403_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ophtha.2018.10.033","article-title":"Effect of an injectable fluocinolone acetonide insert on recurrence rates in chronic noninfectious uveitis affecting the posterior segment: twelve-month results","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.xops.2023.100403_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/ijo.IJO_851_17","article-title":"Changing uveitis patterns in South India - comparison between two decades","volume":"66","author":"Biswas","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2023.100403_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3928\/23258160-20190503-01","article-title":"MUST beg to differ","volume":"50","author":"Albini","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"5","key":"10.1016\/j.xops.2023.100403_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/jop.2012.0180","article-title":"A\u00a0comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis","volume":"29","author":"Arcinue","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.xops.2023.100403_bib16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/archopht.125.11.ecs70063","article-title":"Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants","volume":"125","author":"Goldstein","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.xops.2023.100403_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ophtha.2012.04.030","article-title":"Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema","volume":"119","author":"Campochiaro","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.xops.2023.100403_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2023.100403_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.xops.2023.100403_bib20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/pharmaceutics14040688","article-title":"Biomarkers to predict the success of treatment with the intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema","volume":"14","author":"Kessler","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xops.2023.100403_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00417-021-05504-6","article-title":"Intravitreal fluocinolone acetonide 0.19 mg (Iluvien(R)) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients","volume":"260","author":"Studsgaard","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914523001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:25:37Z","timestamp":1763015137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914523001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2666914523001355"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2023.100403","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 0.2-\u03bcg\/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2023.100403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100403"}}